Share
New Delhi: Bill & Melinda Gates Foundation and Council of Scientific and Industrial Research (CSIR), Indiahave signed a Memorandum of Understanding (MoU) to support the development, conduct and promotion of health research in India. Gates Foundation and CSIRwill worktogether to identify opportunities to initiate scientific and technological collaborations. These will focus on developing and testing new preventions, therapies and interventions that can help to solve major health concerns that affect India and other developing countries.
As per the MoU, areas of research collaboration would include genetic diseases that impact infant and neonatal mortality; new diagnostics and devices for infectious disease and environmental surveillance; development of cost-effective processes for drug, vaccines, biologics, and diagnostics manufacturing; novel microbiome-directed foods; socio-economic impact of science and technological tools; and other areas of health and development.
TATA, CSIR in talks with Moderna to conduct trials, bring COVID-19 vaccine to India
Moderna s vaccine is based on mRNA technology and it 94 percent effective at preventing COVID-19 in people who were given two doses and had no history of the infection.
Feb 01, 2021 11:48:39 IST
TATA Group s newly launched medical venture Tata Medical & Diagnostics is reportedly in talks with Moderna to bring its COVID-19 vaccine to India after conducting clinical trials to ensure its safety and efficacy.
The Economic Times reported that the dialogue is still in its early days and that sources have said that the company would partner up with the Council of Scientific & Industrial Research (CSIR) to carry out the necessary clinical trials of Moderna’s vaccine candidate in India.
Tata Group in talks with Moderna to launch COVID-19 vaccine in India
As per the government s norms, it is mandatory for a foreign vaccine-making firm to conduct at least a Phase-3 trial with Indian volunteers even if it is approved outside India
BusinessToday.In | January 25, 2021 | Updated 11:00 IST
Last year in January, Moderna received fundings from the Coalition for Epidemic Preparedness Innovations to develop a vaccine against the COVID-19 virus
Tata Group s new healthcare venture, Tata Medical and Diagnostics Ltd (TataMD) has started exploratory talks with US biotechnology firm Moderna for a partnership to launch its COVID-19 vaccine in India.
As per the government s norms, it is mandatory for a foreign vaccine-making firm to conduct at least a Phase-3 trial with Indian volunteers even if it is approved outside India.